InnoSEAL™ Hemostatic Adhesive
InnoSEAL™ has the advantage
of having excellent initial hemostasis in the case of a large amount of bleeding or high blood pressure compared with the existing products
Especially in the form of PAD, early hemostasis and compression after vascular intervention can dramatically
improve hemostasis time.
In March 2015, KFDA was approved for this clinical efficacy.
Features
- High absorption ability
- InnoSEAL™ has optimized in PCI (Intercantional cathether procedures) for high speed hemostatic ability to prevent massive bleeding of leakages from damaged wounds.
Indications
- Local Hemostasis
- Blood Vessel Intervention
Download Additional Information
|
| Brochure |